NYU-Manhattan

New York, New York 10016

2 studies enrolling now · 2 studies all time

What they study most

DCIS, Ductal Breast Carcinoma In Situ, G12D Mutated KRAS, Pancreatic Ductal Adenocarcinoma (PDAC), Stage 0 Breast Cancer

Studies at this site

• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer — Recruiting now
• The PREDICT Registry: — Recruiting now